JB
Joel E. Bernstein
President and CEODirector10% Owner
Joel E. BernsteinPresident and CEODirector10% Owner
Joel E. Bernstein insider trades: Winston Pharmaceuticals (WPHM) SEC Form 4 filings
President and CEO, Winston Pharmaceuticals 3 Form 4 filings
3
Form 4 filings
last May 21, 2010
2
Grants and awards
filings
1
Option exercises
filings
1
Company
Companies
Where Joel reports to the SEC
About Joel E. Bernstein's insider trades
Joel E. Bernstein is President and CEO at Winston Pharmaceuticals (WPHM). Joel has not reported an open-market purchase or sale.
Their filings also include grants and awards (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WPHM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.